Missing/wrong data?
Log in to edit
Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial
scientific article published on 14 April 2015
Author/s
author: Axel Le Cesne, Jean-Yves Blay, Piotr Rutkowski, George D Demetri, Zsuzsanna Pápai, Peter Reichardt
Work details
Publication date
April 14, 2015
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.